Infection Control Today - 01/2004: References
JANUARY REFERENCES
SKIN PREP: PREPARING THE HYPERSENSITIVE PATIENT, BY TINABROOKS, PAGE 22.
1. No author. Dorlands Illustrated Medical Dictionary. 29thed. Philadelphia: WB Saunders Co.; 2000. P. 73.
2. Hood GH, Dincher JR. Total Patient Care. 8th ed. St. Louis:Mosby; 1992. P. 797.
3. Spry C. Essentials of Perioperative Nursing. 2nd ed.Gaithersburg: Aspen Publishers; 1997. P. 505.
4. Ancona A, Arevalo A, Macotela E. Contact dermatitis inhospital patients. Dermatologic Clinics. 1990;8:95-105.
5. Nakao M, Nakatani K, Suyama H, Maekawa T, Nakawa M, HanakiC, Kawaguchi R. A case of life-threatening anaphylactoid reation caused bypovidone-iodine. Masui. 1997;46:105-109.
6. Knight BA, Puy R, Douglass J, OHehir RE, Thein F.Chlorhexidine anaphylaxis: a case report and review of the literature. InternalMedicine Journal. 2001;31:436-443.
7. Smit J. Current perspective management on the perioperativemanagement of the latex-allergic patient. CRNA. 1999;10:117-123.
8. Hammarsten R, Hammarsten J, Jemsby P. Preoperative skintesting of materials used in surgical procedures. AORN Journal.2003;77(4):762-6, 769-71.
9. DeWit SC. Essentials of Medical-Surgical Nursing. 4th ed.Philadelphia: WB Saunders Co.; 1998. P. 176.
10. American Academy of Allergy, Asthma & Immunology.www.aaaai.org
RAISING THE STANDARD TO THE STANDARD, BY BECKI HARTER, CST, RCST, CRCST, FEL, PAGE 38.
1. AAMI ST33-1996, ST35 46, 40, 97.
2. AAMI TIR 12-1994.
3. Amsco Steris, operating procedure, Steris Corporation,Erie, Pa., 2002.
4. Getinge Castle, operators manual, Rochester, N.Y., 2002.
5. Reichert M, Young J, Sterilization technology for theHealth Care
Facility, Second Edition, Gaithersburg, Md., AspenPublication, Inc., 1997.
6. Ninemeier JD. Central Service Manual, Fifth Edition,IAHCSMM, Chicago, IL, 2000.
7. Sherman M. Medical Device Packaging Handbook, SecondEdition, Revised and expanded, Marcel Dekker, Inc., New York, 2001.
INVASION OF THE ANTIMICROBIALS, BY JOHN ROARK, PAGE 40.
Robust infectious disease surveillance, including rapid subtyping of influenza A, is essential for early detection, containment, and public health reporting of novel viral threats.
